Clinical differentiation between pediatric pulmonary tuberculosis and Mycoplasma pneumoniae pneumonia (Review).

Publication date: Sep 01, 2026

Differentiating between pediatric pulmonary tuberculosis (TB) and Mycoplasma pneumoniae pneumonia (MPP) is essential due to their overlapping clinical manifestations yet distinct therapeutic approaches. TB is characterized by a chronic progression, accompanied by constitutional symptoms and specific radiological features such as lymphadenopathy and ‘tree-in-bud’ patterns. By contrast, MPP typically presents with an acute onset, marked by a severe paroxysmal dry cough, and is associated with patchy consolidation and ground-glass opacities on imaging studies. Accurate diagnosis relies on molecular assays, such as Xpert MTB/RIF and PCR, alongside serological testing. The treatment regimen for TB involves prolonged administration of multiple drugs, whereas MPP is generally managed with macrolide antibiotics, although rising resistance is a concern. Therefore, the integration of clinical, radiological, and laboratory data is imperative for precise diagnosis and effective management.

Semantics

Original Article